Webinar

Get set for 2025: Mastering the new EU HTA statistical guidelines

Watch the webinar now to learn:

  • The importance of evidence synthesis and statistical methods for integrating data on study drugs. 
  • The evolution, stakeholder involvement, implementation challenges, and innovative approaches within the guidelines. 
  • Potential impacts on decision-making processes within healthcare systems across Europe. 
  • Strategies to enhance accuracy and reliability in HTAs through methodological harmonization.
  • Solutions for implementing these new statistical analysis guidelines effectively. 

Fill out the form below to watch the webinar now.

Pardot Form


headshot
Michael Hennig, Ph.D.
Senior Director, Expertise Line Head HTA Statistics, Cencora PharmaLex
headshot
Ruairi O’Donnell, Ph.D.
EU HTA Lead, Cencora

Related resources

White paper

Capitalizing on biotech collaboration: A CFO’s guide to driving growth
Learn More

Article

The future promise of advanced therapies in ophthalmology
Learn More

Article

Unlock the future of formulary decision-making with AI
Learn More

We’re here to help

Connect with our team today to learn more about how Cencora is helping to shape the future of healthcare.
EU HTA Statistical Guidelines
EU HTA Statistical Guidelines
Don't miss this on-demand webinar featuring Michael Hennig, PhD, Senior Director, Expertise Line Head HTA Statistics at Cencora PharmaLex, and Ruairi O'Donnell, PhD, EU HTA Lead at Cencora, as they shed light on the guidelines for statistical analysis transforming the landscape of European health technology assessment (HTA).  

Scheduled to take effect in January 2025 for oncology and ATMP, these guidelines emphasize evidence synthesis and statistical methods for merging data on study drugs.  

In this interactive session, including a live Q&A with the audience, our experts dive into the intricacies of these guidelines - their evolution, stakeholder involvement, implementation challenges, innovative approaches, adaptability to emerging trends - and discuss their potential impact on decision-making processes within healthcare systems across Europe.  
EU HTA Statistical Guidelines

Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.

Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.